Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dotiapramib tablets in treatment-naive adults with HIV-1 infection
ChiCTR1900027656Phase 4Recruiting
- Sponsor
- Chongqing Public Health Medical Treatment Center
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dolutegravir, abacavir and lamivudine in human immunodeficiency virus infection (HIV), sponsored by Chongqing Public Health Medical Treatment Center. Primary endpoints: HIV RNA, CD4 count and 1 more. Started Nov 2019; status: recruiting.
02
Drugs
dolutegravirabacavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR1900027656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027656.